Secondary Attack Rate
Showing 51 - 75 of >10,000
Left Atrial Appendage Closure as Secondary Prevention of Atrial
Recruiting
- Non-valvular Atrial Fibrillation
- Embolic Stroke
- Transthoracic Echocardiography
-
Jinan, Shandong, China
- +4 more
Dec 15, 2022
Headache Disorders, Primary, Headache Disorders, Secondary, Migraine Trial in Hangzhou
Not yet recruiting
- Headache Disorders, Primary
- +6 more
-
Hangzhou, Zhejiang, ChinaKaiming Liu
Jun 9, 2022
Balloon angiopLasty for Intracranial Atherosclerotic Minor
Not yet recruiting
- Ischemic Stroke
- Submaximal balloon angioplasty
- (no location specified)
Aug 28, 2023
Atrial Fibrillation Trial in Chicago (Parasym)
Completed
- Atrial Fibrillation
- Parasym
-
Chicago, IllinoisThe University of Chicago
Jul 11, 2022
Asthma Attack, Asthma Trial in Singapore (Benralizumab 30 MG/ML [Fasenra], Placebos)
Recruiting
- Asthma Attack
- Asthma
- Benralizumab 30 MG/ML [Fasenra]
- Placebos
-
Singapore, Foreign, SingaporeSingapore General Hospital
Jul 22, 2021
Atrial Fibrillation, Diastolic Dysfunction, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Burlington (As
Recruiting
- Atrial Fibrillation
- +2 more
- As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)
-
Burlington, VermontUniversity of Vermont Medical Center
Feb 28, 2023
Uveitis Trial (Adalimumab plus different doses of oral glucocorticosteroid)
Not yet recruiting
- Uveitis
- Adalimumab plus different doses of oral glucocorticosteroid
- (no location specified)
Nov 1, 2021
Acute Demyelinating Syndrome Trial in France (Immediate Azathioprine (1st attack), Immediate Rituximab (1st attack), Standard of
Not yet recruiting
- Acute Demyelinating Syndrome
- Immediate Azathioprine (1st attack)
- +2 more
-
Besançon, France
- +8 more
Sep 14, 2022
The COPD Attack Study
Completed
- Pulmonary Disease, Chronic Obstructive
- Exacerbation COPD
- It was an observational study
-
Kampala, Uganda
- +1 more
Mar 21, 2023
Hereditary Angioedema Trial in Netherlands, United States (IONIS-PKK-LRx, Placebo)
Ischemic Heart Disease, Acute Coronary Syndrome Trial in Bialystok
Active, not recruiting
- Ischemic Heart Disease
- Acute Coronary Syndrome
-
Białystok, PolandDepartment of Invasive Cardiology, Medical University of Bialyst
Mar 15, 2023
Dementia, Cognitive Change, Stroke Trial (MIND diet intervention, General dietary advice)
Not yet recruiting
- Dementia
- +4 more
- MIND diet intervention
- General dietary advice
- (no location specified)
Jun 17, 2023
Influenza Trial in Baltimore, Durham (Influenza RG-A/Texas/71/2017 (H3N2) Challenge, Placebo)
Recruiting
- Influenza
- Influenza RG-A/Texas/71/2017 (H3N2) Challenge
- Placebo
-
Baltimore, Maryland
- +1 more
Aug 4, 2022
Study on Hospitalization of Children With Bronchial Asthma
Not yet recruiting
- Asthma in Children
- (no location specified)
Mar 23, 2023
Chronic Kidney Diseases, Cardiovascular Diseases, Bleeding Trial in Nottingham (Aspirin)
Recruiting
- Chronic Kidney Diseases
- +2 more
-
Nottingham, United KingdomNottingham Digestive Diseases Centre
Jan 3, 2022
Secondary Acute Myeloid Leukemia Trial in Ann Arbor (Venetoclax, FLAG Protocol)
Not yet recruiting
- Secondary Acute Myeloid Leukemia
- Venetoclax
- FLAG Protocol
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Mar 22, 2023
Exocrine Pancreatic Insufficiency, Acute Pancreatitis Trial in Helsinki
Completed
- Exocrine Pancreatic Insufficiency
- Acute Pancreatitis
-
Helsinki, FinlandHelsinki University Hospital
Aug 15, 2022
Paroxysmal Atrial Fibrillation Trial in Guangzhou (Pulse ablation catheter)
Active, not recruiting
- Paroxysmal Atrial Fibrillation
- Pulse ablation catheter
-
Guangzhou, Guangdong, Chinathe Second Affiliated Hospital of Sun Yat-sen University (Sun Ya
Sep 10, 2023
Transient Ischemic Attack, Ischemic Stroke, Intracerebral Hemorrhage Trial in Philippines
Recruiting
- Transient Ischemic Attack
- +4 more
-
Baguio City, Benguet, Philippines
- +10 more
Sep 9, 2021
Testing VIRTUES Patient Care Sets in Cardiac Patients
Not yet recruiting
- Heart Diseases
- +4 more
- (no location specified)
Jul 15, 2022
Pulmonary Disease, Chronic Obstructive Trial in United States (Stiolto Respimat, ICS (Inhaled Corticosteroid) (Triple therapy),
Completed
- Pulmonary Disease, Chronic Obstructive
- Stiolto Respimat
- +3 more
-
Mobile, Alabama
- +89 more
May 24, 2022
Respiratory Rate Trial in Arnhem (Instructions of breathing)
Not yet recruiting
- Respiratory Rate
- Instructions of breathing
-
Arnhem, NetherlandsRijnstate Hospital
Aug 15, 2023
Secondary Antibody Deficiency Trial (Immunoglobulin replacement therapy (IGRT))
Not yet recruiting
- Secondary Antibody Deficiency
- Immunoglobulin replacement therapy (IGRT)
- (no location specified)
Nov 4, 2022